Michael Platten, MD

Michael Platten, MD

@michael-platten.bsky.social

Neurologist, Chair of Neurology Brain Tumor Immunotherapy @dkfz.bsky.social @platten-lab.bsky.social @uniheidelberg.bsky.social Medical Faculty Mannheim Founder Tcelltech President @eanoassociation.bsky.social Ambassador for the @erc.europa.eu

1.5K followers186 following24 posts

Michael Platten, MD reposted

Michael Platten, MD reposted

Michael Platten, MD reposted

👉 We are excited to announce that the #EANO2025 Abstract Book is now available online! Download & explore it today: lnkd.in/dg79p6wM #AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm

Michael Platten, MD reposted

The October issue of #ScienceImmunology is out! This month's cover highlights a Review that delves into brain tumor development and examines factors contributing to the immunosuppressive brain tumor microenvironment. Learn about this and more: https://scim.ag/46HgHcl

Michael Platten, MD reposted

🧠 Recently published in Neuro-Oncology: EANS–EANO Guidelines on the Extent of Resection in Gliomas. We’re proud to share the outcome of collaborative effort by the joint task force of EANS and EANO, providing evidence-based recommendations for clinical practice. 🔗 academic.oup.com/neuro-oncolo...

Excited to announce that we have completed accrual of the INTERCEPT-H3 trial (NCT04808245). This phase 1 first-in-human trial explores safety and immunogenicity of a long peptide vaccine targeting the clonal driver mutation H3K27M in adult patients with newly diagnosed diffuse midline gliomas 1/

View full thread

Excited to announce that we have completed accrual of the INTERCEPT-H3 trial (NCT04808245). This phase 1 first-in-human trial explores safety and immunogenicity of a long peptide vaccine targeting the clonal driver mutation H3K27M in adult patients with newly diagnosed diffuse midline gliomas 1/

Michael Platten, MD reposted

📣 Have you heard? Registration for #EANO2025, taking place Oct 16-19, 2025 in #Prague (CZ) is open! Don’t miss out on this fantastic experience to meet experts in the field of #NeuroOncology. Early Bird fees available until July 31, 2025. 👉 eano.eu/eano2025/reg... #braincancer #medsky

Michael Platten, MD reposted

🧠 June 8 is #WorldBrainTumorDay — raising awareness & understanding of brain tumors. EANO supports progress in #NeuroOncology through research, education & collaboration. 🔗 Learn more: www.eano.eu #btsm #BrainTumor #Oncology

Michael Platten, MD reposted

The SynthImmune project by Heidelberg University& partner institutes advances a "bottom-up" synthetic biology approach to immunotherapies. Hoping they do well in the German government's Excellence Strategy—anticipating the announcement on 22 May. Perspective article: www.nature.com/articles/s41...

nature.comBottom-up synthetic immunology - Nature NanotechnologyThis Perspective highlights bottom-up molecular engineering and modular nanobiotechnological approaches for developing effective immunotherapeutics and their potential in personalized medicine.

Michael Platten, MD reposted

🗓️ Only one week to go! The abstract submission deadline for #EANO2025 in #Prague is approaching fast. This is your opportunity to share your findings, collaborate with peers, and be recognized in the field of #NeuroOncology. Submit your abstract now: www.eano.eu/eano2025/ #btsm

Michael Platten, MD reposted

Do you want to do your #postdoc in #cancerresearch with the most prestigious #fellowship in Europe? Apply to DKFZ Marie Skłodowska Curie MasterClasses by May 19. Projects in #cellandmolecularbiology #genomics #bioinformatics #immunology #medicaltechnology, #epidemiology. Apply here: t1p.de/nx6tu

Michael Platten, MD reposted

🚀 New publication! We developed a PTPRZ1-specific TCR-T cell therapy for glioblastoma. 🔬 Key findings: ✅ Identified a PTPRZ1-reactive TCR from a vaccinated patient ✅ Kills glioblastoma cells with no off-target effects ✅ Eliminates tumors in murine brain models 🔗 www.nature.com/articles/s41...

nature.comVaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen - Nature CommunicationsVaccination in glioblastomas does lead to the emergence of tumour-antigen-specific T cells but T cell dysfunction, poor tumour infiltration and persistence hinder efficient tumour killing. Here author...

Michael Platten, MD reposted

Don’t miss our i2 seminar today at 4 pm where we will hear more about immunogenic cancer editopes and the lineage tree of tissue macrophage development. Join us for a lively discussion and snacks and drinks! 🧪 Today at 4pm in the main building 👇

The i2 seminars are back on Thursday, April 17, at 4 pm with two talks by Dr. Bea Casati, Postdoc in the Papavasiliou Lab, and Larissa Frank, PhD student in the Rodewald Lab. Save the date and join us for a lively discussion! @dkfz.bsky.social @beacasati.bsky.social @larissafrank.bsky.social

Michael Platten, MD reposted

Don't forget to register - only one week left!

VIB Training & Conferences@vibtrainconf.bsky.social

🕛 You have until the 23rd of April to register for #INCI25. After that, you will miss the latest #cancerbiology and #immunotherapy research developments. Claim your spot & see you in beautiful Bruges while there’s still time: vibbio.tech/4ic2SEZ #CancerBiology #Immunology #immunotherapy

Michael Platten, MD reposted

🚀 Just 2 weeks left to submit your abstract for #EANO2025 in #Prague! Don't miss your chance to share your research with the world. Submit your work by April 30 and join us for an incredible event this October. We can't wait to see your contributions! 🔬 eano.eu/eano2025/

Herzlichen Glückwunsch: 🏆️ Juniorprofessor Dr. Peter Andre @peterandre.bsky.social , #Wirtschaftspolitik, @safefrankfurt.bsky.social @goetheuni.bsky.social 🏆️ Dr. Lukas Bunse @lukasbunse.bsky.social, #Neurologie, Universitätsmedizin Mannheim, Universität Mannheim 2/6

Michael Platten, MD reposted

🚀From Glasgow to Prague: Shaping the Future Together! #EANO2024 in Glasgow was a huge success with unforgettable moments & inspiring talks! Watch the highlights bit.ly/3WL1oKg and get excited for #EANO2025 in Prague! What are you most excited about? #NeuroOncology

Michael Platten, MD reposted

📅 Mark your calendars! Abstract submissions for #EANO2025 are due April 30. Don’t miss your chance to showcase your #NeuroOncology research this October! 🌍✨ 🔬 Submit now: www.eano.eu/eano2025/abs... #btsm #neurosurgery #glioma #RadOnc #BrainCancer #cancernurse #AHP

Michael Platten, MD reposted

🚀Abstract submission for #EANO2025 is open! Share your #NeuroOncology research at the 20th #EANO Meeting in Prague, Oct 16-19, 2025. We can't wait to see your contributions! 🗓️ Deadline: April 30, 2025, 23:59 CEST. 🔗 Details: www.eano.eu/eano2025/abs... #btsm #braintumor

Michael Platten, MD reposted

🚨 Still 3 days: #EANO Seminars 2026 – Call for Applications! 📅 Deadline: Jan 8, 2025 📍 Location: University/hospital campus preferred Learn more 👉eano.eu Let’s bring #EANOSeminars to your region! #NeuroOncology #btsm

Michael Platten, MD reposted

📢 Reminder: EANO Seminars 2026 – Call for Applications! Don't miss the chance to host this educational event on #CNSOncology! 📅 Deadline: Jan 8, 2025 📍 Location: University/hospital campus preferred Learn more at eano.eu Let’s bring #EANOSeminars to your region!

Great fun to write this perspective with @lukasbunse.bsky.social @platten-lab.bsky.social @dkfz-iic.bsky.social @dkfz.bsky.social on a highly interesting study by the Bardeesy Lab. This study provides additional mechanistic rationale to combine IDH inhibitors with T cell activating therapies.

NEJM.org@nejm.org

A recent study unpicks a key immune-mediated mechanism of mutant IDH–blocking drugs such as vorasidenib in the treatment of IDH-mutant glioma. Learn more in a new Clinical Implications of Basic Research article: nej.md/4f3dIMf #MedSky